These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 26772439)
1. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI). Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439 [TBL] [Abstract][Full Text] [Related]
2. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease. Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641 [TBL] [Abstract][Full Text] [Related]
3. Amyloid imaging using high-field magnetic resonance. Amatsubo T; Yanagisawa D; Morikawa S; Taguchi H; Tooyama I Magn Reson Med Sci; 2010; 9(3):95-9. PubMed ID: 20885081 [TBL] [Abstract][Full Text] [Related]
4. Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques. Sato K; Higuchi M; Iwata N; Saido TC; Sasamoto K Eur J Med Chem; 2004 Jul; 39(7):573-8. PubMed ID: 15236837 [TBL] [Abstract][Full Text] [Related]
5. Preferred features of a fluorine-19 MRI probe for amyloid detection in the brain. Yanagisawa D; Taguchi H; Ibrahim NF; Morikawa S; Shiino A; Inubushi T; Hirao K; Shirai N; Sogabe T; Tooyama I J Alzheimers Dis; 2014; 39(3):617-31. PubMed ID: 24246421 [TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains. Dudeffant C; Vandesquille M; Herbert K; Garin CM; Alves S; Blanchard V; Comoy EE; Petit F; Dhenain M Sci Rep; 2017 Jul; 7(1):4955. PubMed ID: 28694463 [TBL] [Abstract][Full Text] [Related]
7. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI. Huddleston DE; Small SA Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505 [TBL] [Abstract][Full Text] [Related]
8. PET of brain amyloid and tau in mild cognitive impairment. Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990 [TBL] [Abstract][Full Text] [Related]
9. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease. Kudo Y Minim Invasive Ther Allied Technol; 2006; 15(4):209-13. PubMed ID: 16966133 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging. Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859 [TBL] [Abstract][Full Text] [Related]
11. Current status of PET-imaging probes of β-amyloid plaques. Koo J; Byun Y Arch Pharm Res; 2013 Oct; 36(10):1178-84. PubMed ID: 23812777 [TBL] [Abstract][Full Text] [Related]
13. [Amyloid-plaque imaging of the brain using PET]. Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer's disease. Setti SE; Das N; Raymick J; Hanig J; Sarkar S Metab Brain Dis; 2022 Mar; 37(3):639-651. PubMed ID: 35064472 [TBL] [Abstract][Full Text] [Related]
15. Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer's disease mouse model. Frost GR; Longo V; Li T; Jonas LA; Judenhofer M; Cherry S; Koutcher J; Lekaye C; Zanzonico P; Li YM Sci Rep; 2020 Jun; 10(1):10379. PubMed ID: 32587315 [TBL] [Abstract][Full Text] [Related]
16. Feasibility and acceptance of simultaneous amyloid PET/MRI. Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367 [TBL] [Abstract][Full Text] [Related]
17. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains. Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524 [TBL] [Abstract][Full Text] [Related]
18. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
19. Preliminary PET Study of Oh SJ; Kim MH; Han SJ; Kang KJ; Ko IO; Kim Y; Park JA; Choi JY; Lee KC; Chi DY; Lee YJ; Kim KM Mol Pharm; 2017 Sep; 14(9):3114-3120. PubMed ID: 28737945 [TBL] [Abstract][Full Text] [Related]